| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-32 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-673
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-757
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-643 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-10 |
| filingDate |
2018-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f830ed4d61a40d421da3df9fbfa95ce0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87d57dad4d69b3513f9bef2edecb5de9 |
| publicationDate |
2019-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019127306-A1 |
| titleOfInvention |
Polycyclic carbogenic molecules and uses thereof as anti-cancer agents |
| abstract |
Disclosed are new polycyclic carbogenic molecules and their methods of synthesis. The new polycyclic carbogenic molecules may be utilized in anti-cancer therapies. In particular, the polycyclic carbogenic molecules may be formulated as pharmaceutical compositions that comprise the small molecules, which compositions may be administered in methods of treating and/or preventing cell proliferative diseases and disorders such as cancer. The new polycyclic carbogenic molecules may be prepared from vinyl- or allyl-substituted cyclohexenone precursors via preparation of a silyl bis-enol ether intermediate. |
| priorityDate |
2017-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |